Loyd Tomlinson, DPM
Foot & Ankle Surgery · Springfield, MANPI 1811341811
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Kairos Surgical Inc at 38.6% of the total. Reporting peaked in 2022 at $2,468 and has fallen 93.7% since, to $154 in 2025.
Across 43 payments — averaging $146.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$2K
- Arthrex$1K
- Paragon 28, Inc.$472
- Stryker$368
- MVP Orthopedics Inc$275
- Abbott$272
- plus $1K from 9 others
What the payments were for
- Travel & lodging$5338%
- Food & beverage$2,16234%
- Education$3,60057%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 4 | $2,427 |
| Arthrex | 4 | $1,452 |
| Paragon 28, Inc. | 3 | $472 |
| Stryker | 6 | $368 |
| MVP Orthopedics Inc | 4 | $275 |
| Abbott | 2 | $272 |
| KCI USA, Inc. | 1 | $235 |
| Bard Peripheral Vascular, Inc. | 1 | $154 |
| Derma Sciences, Inc. | 1 | $147 |
| Orthofix Medical, Inc. | 7 | $101 |
| Royal Biologics, Inc. | 1 | $100 |
| Integra Lifesciences Corporation | 3 | $93 |
| Cardiovascular Systems Inc. | 1 | $87 |
| Organogenesis Inc. | 4 | $81 |
| Acell, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapidus Nail$337
- Proclaim Family of SCS IPGs$272
- VAC VERAFLO$235
- RotarexS 6 F x 135 cm$154
- AMNIOEXCEL$147
- TCC-EZ$147
- PRIMATRIX$147
- IDRT$147
- OMNIGRAFT$147
- ORTHOLOC 3DI$138
How this compares
$6,295 in reported general payments places this provider in the 80th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 434 | $11,374 |
| Ketoconazole | 159 | $4,493 |
| Diclofenac Sodium | 126 | $2,571 |
| Terbinafine Hcl | 218 | $2,028 |
| Meloxicam | 138 | $1,002 |
| Ciclopirox | 44 | $963 |
| Tacrolimus | 13 | $937 |
| Oxycodone Hcl | 86 | $595 |
| Silver Sulfadiazine | 59 | $574 |
| Doxycycline Monohydrate | 58 | $500 |
| Ibuprofen | 37 | $282 |
| Gabapentin | 33 | $200 |
| Hydrocortisone | 24 | $185 |
| SsdSilver Sulfadiazine | 21 | $182 |
| Methylprednisolone | 15 | $162 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Springfield
- Craig LareauSpringfield$115K
- Christopher WolfSpringfield$4K
- Harry SchneiderCambridge$174K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Richard BakerHyannis$16K
- Mark SlovenkaiWaltham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.